What Happened to Luminello? A Psychiatry EHR Post-Mortem

Luminello, a psychiatry-specific EHR that thousands of solo prescribers built their practice around, no longer exists. SimplePractice announced its purchase of Luminello's assets on August 3, 2023, for up to $19.6 million, and shut the platform down the following spring, giving solo accounts roughly two months' notice before their migration deadline. Two years later, the useful story is what the shutdown exposed: platforms end, your data doesn't automatically come with you when they do, and a surprising number of psychiatrists are apparently still typing "luminello login" into a search bar that leads nowhere.

What led to Luminello's shutdown?

Read that middle row again: the company that had just bought Luminello was itself acquired and taken private within six months of announcing the deal. A specialty EHR serving a few thousand prescribers changed hands twice in less than a year, and neither transaction was about the software Luminello's users actually cared about.

For years, Luminello was the answer prescribers reached for when a general practice-management platform didn't handle e-prescribing. Plenty of practices ran it for exactly that one job, sometimes pairing it with a separate system for everything else, sometimes building their entire chart around it because it was one of the few platforms that let a psychiatrist chart and prescribe controlled substances from a single login. That specific combination, one login for both jobs, is what actually disappeared when the platform shut down, and it's worth naming plainly.

How rough was the forced migration?

Public accounts from the transition describe a rougher exit than a routine software swap. One physician who documented the migration in real time reported that Luminello's bulk-export function, the mechanism for pulling your own charts out, worked intermittently and sometimes took over a week to generate a zip file, and that the download button disabled itself after a single use. Anything charted after that one export was never captured. On the receiving end, SimplePractice's import reportedly pulled client lists but not clinical documentation, diagnosis and treatment plans, billing history, or existing calendars, so practices that expected a like-for-like transfer got a client roster and a blank chart. Several accounts describe being downgraded from a promised read-only view of the old system to export-only access, and losing custom intake forms and e-signed consent documents in the process.

Practitioners on the Student Doctor Network forums added complaints on top of the export problems: features missing from SimplePractice at the time, including lab ordering, e-prescribing, and clinical snippets or dot phrases; calendar display bugs; and communication they described as rushed and pressuring, with short windows to finalize paperwork. None of this means every migration went badly. It means the usual failure modes of a forced EHR exit (incomplete exports, missing features on the landing platform, a compressed timeline) all showed up here at once, in public, on a deadline nobody at the receiving end chose.

Where did people land?

No single platform absorbed Luminello's users. The reported destinations, factually and without a verdict on any of them:

• SimplePractice, the default option for anyone who didn't actively choose to leave, since it was already holding the client list.
• IntakeQ/PracticeQ, cited for forms and booking, though e-prescribing was itself a bolt-on there for years rather than a native feature (we covered that history in our EHR comparison).
• Osmind, built specifically around psychiatric measurement-based care and interventional workflows; we go deep on its current pricing and tradeoffs in our Osmind review.
• Valant, Charm, and Sessions Health paired with a separate e-prescribing tool, each mentioned by practitioners moving off Luminello, with the Sessions-plus-iPrescribe combination being the clearest example of exactly the two-system pattern this post is about: a practice that had one login for charting and prescribing went back to running two.

Why does "luminello login" still get searched, two years on?

As of our July 2026 keyword check, "luminello" itself still pulls roughly 250 searches a month, and the busiest query in the cluster is still "luminello login". More than two years after the platform's last patient chart closed, people are still searching for a login page that doesn't exist. Read that as a data point about how much workflow, muscle memory, and unfinished business gets built into an EHR once you've run a practice on it for years, and how much of that doesn't transfer when the platform disappears out from under you. If you're picking a new system today, assume you'll be at least as attached to it in three years as those searchers still are to Luminello, and choose accordingly.

What should you demand from any EHR before you sign?

Luminello's exit is a specific case of a general risk, and the checklist below is what it should change about how you evaluate any practice software, including whatever you're on right now.

1. Get export terms in writing at signup, while asking costs you nothing. Ask exactly what format an export comes in, whether there's a one-time-use limit on pulling it, and whether clinical documentation, billing history, and your calendar are included alongside patient demographics. By multiple accounts, Luminello's own export worked exactly the way you don't want: usable once, PDF-only, and gone after that.
2. Test your exit while you still have full access. Run a real export in year one, while nothing is on fire, and actually open what comes out. A forced migration deadline is the worst possible moment to discover the file format is unusable or the export button doesn't do what the sales page implied.
3. A bolt-on stack inherits every vendor's roadmap risk along with its features. If your entire prescribing workflow rides on the one platform you added purely for e-prescribing, that vendor's acquisition risk, funding risk, and shutdown risk are now your risk too, even though you never evaluated them for anything but one job.
4. An acquisition clock ticks louder on a niche platform than a broad one. A specialty EHR serving a small, devoted user base is a natural tuck-in acquisition for a larger company buying the customer list, and preserving the product those customers loved is a separate decision the buyer makes later, if at all. That's a structural feature of small, well-loved vertical software generally, and it's a fair question to ask directly on any sales call: what happens to my chart if you get bought.

If the reason a platform like Luminello mattered to you was the login count, one system for charting and e-prescribing instead of two separate ones that can each break on their own schedule, that's worth shopping for as a criterion the next time you evaluate a platform. It's the same reason Eureka builds e-prescribing with EPCS into the same login as the chart, notes, and superbills, so it's a live option worth including on your list. Whichever platform you land on, run all four checks above before you import a single patient, on Eureka or anyone else. The same due-diligence habit applies if you're re-evaluating insurance-panel platforms at the same time; we ran the equivalent comparison for Headway, Alma, and Grow Therapy.

Luminello's shutdown didn't invent any of this risk. It just made all of it happen to real practices, on a deadline nobody chose, in the same few months.